A073: Efficacy and safety of quinapril 40 mg in uncontrolled hypertension. victoria study

Last Joint National Committee (JNC) recommendations are stricter, especially with hypertensive patients with associated risk factors. Our objective is to determine if the convenience in dosage range in monotherapy could improve hypertensive control. Victoria Study was designed in order to evaluate t...

Full description

Saved in:
Bibliographic Details
Published in:American journal of hypertension 2000-04, Vol.13 (S2), p.138A-138A
Main Authors: Pueyo, C., Díaz, C., Sol, J.M., Masramon, X., Hernández, G.
Format: Article
Language:English
Subjects:
efficacy
Hypertension
quinapril
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Last Joint National Committee (JNC) recommendations are stricter, especially with hypertensive patients with associated risk factors. Our objective is to determine if the convenience in dosage range in monotherapy could improve hypertensive control. Victoria Study was designed in order to evaluate the efficacy and safety of Quinapril 40 mg in 22,000 patients treated during 8 weeks. The study began in March 1999. In November 1999 we obtained the information of 2012 patients, 54% males, 15% diabetics and 10% with cardiovascular disease. Most of them (71%) were previously treated with anti-hypertensive treatment. 1% had controlled sistolic blood pressure (SBP) (
ISSN:0895-7061
1879-1905
1941-7225
DOI:10.1016/S0895-7061(00)00606-3